Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. Acute hepatitis
3. Acute viral hepatitis
4. Causes of viral hepatitis
5. Signs and symptoms of acute hepatitis
6. Diagnosis of acute hepatitis
7. Acute liver failure
8. Epidemiology of acute liver failure
9. Hepatitis A virus infection
10. Infectivity
11. Acute hepatitis A (1)
12. Acute hepatitis A (2)
13. Acute hepatitis A - clinical course
14. Acute hepatitis A - complications
15. Acute hepatitis laboratory diagnosis
16. Serological course of acute hepatitis A
17. Acute hepatitis A: management
18. Hepatitis A: prevention and control
19. HAV: recommendations for active immunisation
20. Acute hepatitis B
21. Virology of hepatitis B
22. Geographic distribution of chronic HBV infection
23. Immune response hepatitis B
24. Cellular immune response acute hepatitis B
25. Natural history and immune responses in HBV
26. Hepatitis B during pregnancy
27. Clinical course of acute hepatitis B (1)
28. Clinical course of acute hepatitis B (2)
29. Serological course of acute hepatitis B
30. Hepatitis B: genotype epidemiology
31. Treatment of acute hepatitis B
32. Currently available oral antivirals
33. Hepatocellular carcinoma
34. Prevention of hepatitis B (1)
35. Prevention of hepatitis B (2)
36. Preventing mother-infant transmission of HBV
37. Prophylaxis HBV chemotherapy
38. Acute hepatitis C
39. Estimated HCV prevalence by region
40. Worldwide genotype distribution
41. Transmission of hepatitis C
42. Sexual transmission of hepatitis C
43. Incidence of acute of symptomatic hepatitis C
44. HCV background epidemiology (CDC)
45. Clinical course of HCV infection
46. Clinical course: acute hepatitis C
47. Groups at risk of HCV infection
48. Additional sources of HCV infection
49. Diagnosis of acute hepatitis C (CDC definition)
50. Acute resolving HCV infection
51. Diagnosis of acute hepatitis C
52. Immune clearance of acute hepatitis C (1)
53. Immune clearance of acute hepatitis C (2)
54. Recovery from acute hepatitis C
55. Pathology of acute hepatitis C
56. Hepatitis C chronic hepatitis
57. Management of acute hepatitis C (1)
58. Management of acute hepatitis C (2)
59. HCV vaccine intrinsic difficulties
60. Control of infection: HCV
61. Acute hepatitis D
62. Virology of hepatitis D (1)
63. Virology of hepatitis D (2)
64. Epidemiology of HDV
65. Epidemic forms of HDV
66. HDV modes of transmission
67. Diagnosis of HDV infection
68. Coinfection versus superinfection
69. HDV diagnostic tests
70. HBV - HDV coinfection typical serologic course
71. HBV - HDV superinfection serologic course
72. Clinical features of acute illness
73. Chronic hepatitis D
74. Treatment
75. Acute hepatitis E (1)
76. Geographic distribution of hepatitis E
77. Epidemiology of HEV
78. Epidemiology: developed countries
79. Acute hepatitis E (2)
80. Acute hepatitis E: clinical course
81. Acute hepatitis E in the developed world
82. Chronic hepatitis E
83. Hepatitis E diagnosis
84. Serological course of acute hepatitis E
85. Hepatitis E: management

Topics Covered

• Acute viral hepatitis: causes, signs, symptoms and diagnosis
• Acute liver failure including epidemiology
• Acute hepatitis A (diagnosis, clinical & serological course, complications, management, prevention & control)
• Acute hepatitis B (virology, geo-distribution, immune response, pregnancy, clinical & serological course, epidemiology, treatment, prevention)
• Chronic Hepatitis B
• Hepatocellular carcinoma
• Acute hepatitis C (prevalence, diagnosis, clinical course, transmission, immune clearance, management)
• Hepatitis C chronic hepatitis
• Acute hepatitis D (virology, epidemiology, diagnosis, transmission)
• Chronic hepatitis D
• Coinfection versus superinfection (HBV
• HDV)
• Acute hepatitis E (distribution, epidemiology, diagnosis, clinical & serological course, management)
• Chronic hepatitis E
• Currently available oral antivirals

Links

Series:

• Gastroenterology and Hepatology

Categories:

• Clinical Practice

Therapeutic Areas:

• Gastroenterology & Nephrology

Talk Citation

Publication History

• Published on April 4, 2012
• Archived on June 13, 2019

Financial Disclosures

• Prof. Geoffrey Dusheiko has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.